Internal Medicine · Florissant, MO
NPI
1184685455
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
6
Hospital affiliations
91 Florissant Oaks Shop Ctr
Florissant, MO, 63031
Phone (314) 831-8600
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
1,262 services
Medicare patients, 2024
380
Average age 75
Drug cost, 2024
$1.4M
15,087 prescriptions
Company payments, 2025
$760
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael C Treisman was code 99214 (office e&m - established), 595 times for 359 patients. In total Michael C Treisman billed 1,262 services in 32 codes, and Medicare paid $92K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-04-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 595 | 359 | $71.82 | $43K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 250 | 250 | $123.97 | $31K |
| G0008 Administration of influenza virus vaccine | Office | 54 | 52 | $31.21 | $1,685 |
| 90662 Vaccine Product | Office | 49 | 47 | $81.01 | $3,970 |
| 99213 Office E&M - Established | Office | 42 | 41 | $53.50 | $2,247 |
By year: 2022 $125K for 1,662 services; 2023 $110K for 1,338 services; 2024 $92K for 1,262 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 25 | 20 | $2.97 | $74.28 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael C Treisman prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,001 prescriptions and refills. In total Michael C Treisman wrote 15,087 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,001 | 2,892 | 312 | $6,993 |
| Alprazolam Generic | 728 | 870 | 138 | $3,090 |
| Amlodipine Besylate Generic | 579 | 1,705 | 196 | $2,381 |
| Levothyroxine Sodium Generic | 416 | 1,235 | 124 | $3,781 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 409 | 410 | 98 | $9,659 |
| Lisinopril Generic | 375 | 1,061 | 122 | $1,968 |
| Tramadol Hcl Generic | 340 | 343 | 71 | $2,152 |
| Omeprazole Generic | 281 | 729 | 94 | $4,018 |
| Hydrochlorothiazide Generic | 257 | 783 | 97 | $889 |
| Losartan Potassium Generic | 235 | 656 | 71 | $1,499 |
| Simvastatin Generic | 231 | 641 | 69 | $1,288 |
| Gabapentin Generic | 231 | 403 | 63 | $4,315 |
| Metoprolol Succinate Generic | 225 | 629 | 72 | $2,323 |
| Tizanidine Hcl Generic | 222 | 274 | 82 | $2,147 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 201 | 267 | 62 | $4,266 |
Brand drugs: 1,978 claims; generic drugs: 13,017 claims; opioid claims: 1,067.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael C Treisman $760 ($760 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $220.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 14 | $220 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $143 |
| GlaxoSmithKline, LLC. GSK | 5 | $88.05 |
| Lilly USA, LLC LLY | 3 | $58.37 |
| Novo Nordisk Inc NVO | 3 | $55.66 |
| Amgen Inc. AMGN | 2 | $39.18 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $35.1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $31.77 |
| Medtronic, Inc. MDT | 1 | $20.45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $20.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.